Regions of beta 2 and beta 4 responsible for differences between the steady state dose-response relationships of the alpha 3 beta 2 and alpha 3 beta 4 neuronal nicotinic receptors
Abstract
We constructed chimeras of the rat beta 2 and beta 4 neuronal nicotinic subunits to locate the regions that contribute to differences between the acetylcholine (ACh) dose-response relationships of the alpha 3 beta 2 and alpha 3 beta 4 receptors. Expressed in Xenopus oocytes, the alpha 3 beta 2 receptor displays an EC50 for ACh approximately 20-fold less than the EC50 of the alpha 3 beta 4 receptor. The apparent Hill slope (n(app)) of alpha 3 beta 2 is near one whereas the alpha 3 beta 4 receptor displays an n(app) near two. Substitutions within the first 120 residues convert the EC50 for ACh from one wild-type value to the other. Exchanging just beta 2:104-120 for the corresponding region of beta 4 shifts the EC50 of ACh dose-response relationship in the expected direction but does not completely convert the EC50 of the dose- response relationship from one wild-type value to the other. However, substitutions in the beta 2:104-120 region do account for the relative sensitivity of the alpha 3 beta 2 receptor to cytisine, tetramethylammonium, and ACh. The expression of beta 4-like (strong) cooperativity requires an extensive region of beta 4 (beta 4:1-301). Relatively short beta 2 substitutions (beta 2:104-120) can reduce cooperativity to beta 2-like values. The results suggest that amino acids within the first 120 residues of beta 2 and the corresponding region of beta 4 contribute to an agonist binding site that bridges the alpha and beta subunits in neuronal nicotinic receptors.
Additional Information
© 1995 by The Rockefeller University Press. RUP grants the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode. Original version received 25 May 1994 and accepted version received 10 February 1995. We thank Jeremy Gollub and Pumima Deshpande for technical assistance in oocyte injection and construction of some chimeras. This work was supported by grants from the National Institute of Health (NS-11756 California Tobacco-Related Disease Program (1RT-0365, 1RT-0286).Attached Files
Published - COHjgp95.pdf
Files
Name | Size | Download all |
---|---|---|
md5:23895c4a1ede65d1d721abce39f1fcd9
|
1.3 MB | Preview Download |
Additional details
- PMCID
- PMC2216958
- Eprint ID
- 10849
- Resolver ID
- CaltechAUTHORS:COHjgp95
- NIH
- NS-11756
- California Tobacco-Related Disease Research Program
- 1RT-0365
- California Tobacco-Related Disease Research Program
- 1RT-0286
- Created
-
2008-06-13Created from EPrint's datestamp field
- Updated
-
2021-11-08Created from EPrint's last_modified field